Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Receivables - Net: 2020-2025

Historic Receivables - Net for Cellebrite DI (CLBT) over the last 3 years, with Sep 2025 value amounting to $104.2 million.

  • Cellebrite DI's Receivables - Net rose 11.17% to $104.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $104.2 million, marking a year-over-year increase of 11.17%. This contributed to the annual value of $82.4 million for FY2024, which is 6.59% up from last year.
  • Cellebrite DI's Receivables - Net amounted to $104.2 million in Q3 2025, which was up 11.89% from $93.1 million recorded in Q2 2025.
  • In the past 5 years, Cellebrite DI's Receivables - Net registered a high of $104.2 million during Q3 2025, and its lowest value of $67.5 million during Q4 2021.
  • Moreover, its 3-year median value for Receivables - Net was $82.4 million (2025), whereas its average is $85.3 million.
  • Per our database at Business Quant, Cellebrite DI's Receivables - Net decreased by 1.89% in 2023 and then rose by 20.52% in 2025.
  • Cellebrite DI's Receivables - Net (Quarterly) stood at $67.5 million in 2021, then increased by 16.67% to $78.8 million in 2022, then declined by 1.89% to $77.3 million in 2023, then rose by 6.59% to $82.4 million in 2024, then climbed by 11.17% to $104.2 million in 2025.
  • Its Receivables - Net was $104.2 million in Q3 2025, compared to $93.1 million in Q2 2025 and $82.4 million in Q1 2025.